Edition:
United States

Bioverativ Inc (BIVV.OQ)

BIVV.OQ on NASDAQ Stock Exchange Global Select Market

56.11USD
17 Nov 2017
Change (% chg)

$0.82 (+1.48%)
Prev Close
$55.29
Open
$54.99
Day's High
$56.19
Day's Low
$54.98
Volume
287,774
Avg. Vol
368,349
52-wk High
$64.40
52-wk Low
$41.21

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 0.72 December 18 Nov 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 4 4 3 3
(2) OUTPERFORM 3 1 1 1
(3) HOLD 6 7 8 7
(4) UNDERPERFORM 1 1 1 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.29 2.38 2.54 2.50

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 11 301.44 310.11 296.00 --
Quarter Ending Mar-18 7 302.62 326.16 285.00 --
Year Ending Dec-17 14 1,146.89 1,207.68 1,136.00 --
Year Ending Dec-18 14 1,297.57 1,382.71 1,235.00 --
Earnings (per share)
Quarter Ending Dec-17 11 0.72 0.77 0.59 --
Quarter Ending Mar-18 7 0.74 0.83 0.68 --
Year Ending Dec-17 15 3.04 3.21 2.69 --
Year Ending Dec-18 15 3.33 4.21 2.72 --
LT Growth Rate (%) 4 14.65 18.41 9.00 --

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 285.49 291.60 6.11 2.14
Quarter Ending Jun-17 268.00 289.10 21.10 7.87
Quarter Ending Mar-17 247.82 259.10 11.28 4.55
Quarter Ending Dec-16 255.33 256.20 0.87 0.34
Earnings (per share)
Quarter Ending Sep-17 0.69 0.80 0.11 16.48
Quarter Ending Jun-17 0.71 0.88 0.17 23.53
Quarter Ending Mar-17 0.62 0.68 0.06 9.45
Quarter Ending Dec-16 0.63 0.62 0.01 1.98

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 301.44 301.44 295.36 294.50 --
Quarter Ending Mar-18 302.62 302.62 291.29 290.38 --
Year Ending Dec-17 1,146.89 1,146.89 1,134.31 1,132.55 --
Year Ending Dec-18 1,297.57 1,297.57 1,273.79 1,273.79 --
Earnings (per share)
Quarter Ending Dec-17 0.72 0.72 0.69 0.68 --
Quarter Ending Mar-18 0.74 0.74 0.71 0.70 --
Year Ending Dec-17 3.04 3.03 2.93 2.92 --
Year Ending Dec-18 3.33 3.31 3.21 3.20 --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 7 1
Quarter Ending Mar-18 0 0 2 0
Year Ending Dec-17 0 0 8 2
Year Ending Dec-18 0 0 6 3
Earnings
Quarter Ending Dec-17 0 1 7 2
Quarter Ending Mar-18 1 0 4 0
Year Ending Dec-17 1 0 11 1
Year Ending Dec-18 2 0 6 3